Open an account

Gladstone Capital

GLAD · NASDAQ

$18.47−$0.03 (−0.16%)TodayMarket closed ·
Prev close $18.50

About GLAD

Gladstone Capital Corp. is real estate investment trust, which owns net leased industrial, commercial, retail property and selectively makes long-term industrial and commercial mortgage loans. The firm invests in debt and equity securities, consisting primarily of secured first and second lien term loans to lower middle market businesses. Its investment objectives are to achieve and grow current income by investing in debt securities of established lower middle market companies (companies with annual earnings before interest, taxes, depreciation and amortization (EBITDA) of $3 million to $25 million) in the United States that will provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities, in connection with its debt investments, that can grow over time to permit it to sell its equity investments for capital gains. The company is externally managed by Gladstone Management Corporation.

Employees
73
Headquarters
McLean, Virginia
Listed
Aug 23, 2001
Sector
Financials
Industry
Capital Markets
Website
gladstonecapital.com

GLAD key statistics

Market cap
417.29M
Price-earnings ratio
9.02
Dividend yield
10.44%
Average volume
162.40K
Volume
160.04K
Open price
$18.50
High today
$18.75
Low today
$18.42
52 Week high
$21.73
52 Week low
$16.54

Gladstone Capital (GLAD) at a glance

As of Oct 20, 2026, Gladstone Capital (GLAD) shares are priced at $18.47, giving the company a market cap of 417.29M, a price-to-earnings ratio of 9.02 and a dividend yield of 10.44%.

Today the stock has traded between $18.42 and $18.75. The current price is 0.3% above the day's low and 1.5% below its high.

Volume so far is 160.04K shares, in line with the average of 162.40K shares a day.

Over the past year Gladstone Capital has ranged from $16.54 to $21.73, and now sits 37% of the way up that range.

Gladstone Capital met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.49 per share against an estimate of $0.4914.

The average analyst price target is $22.69, 22.9% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 6 analystsAvg $22.69
Low
$22.22
Now
$18.47
High
$24.15

GLAD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 3.1% on average.

  1. Q3 FY24: reported $0.57 per share against an estimate of $0.5435
  2. Q4 FY24: reported $0.50 per share against an estimate of $0.5406
  3. Q1 FY25: reported $0.50 per share against an estimate of $0.5715
  4. Q2 FY25: reported $0.50 per share against an estimate of $0.5168
  5. Q3 FY25: reported $0.50 per share against an estimate of $0.51
  6. Q4 FY25: reported $0.52 per share against an estimate of $0.5129
  7. Q1 FY26: reported $0.39 per share against an estimate of $0.491
  8. Q2 FY26: reported $0.49 per share against an estimate of $0.4914

GLAD news

  • Press releasePRNewswire

    Cathay Capital Invests in Ascendia Autism Care to Expand Access to Evidence-Based ABA Therapy for Children and Families

  • A Glimpse of Gladstone Cap's Earnings Potential

Similar companies

Companies in the same industry as Gladstone Capital

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.